Llwytho...
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
BACKGROUND: The use of anthracyclines is limited by the occurrence of cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline derivates have been studied. OBJECTIVES: To determine the occurrence of cardiotoxicity with the use of different anthracycline derivates in cance...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2010
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457588/ https://ncbi.nlm.nih.gov/pubmed/20464735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005006.pub4 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|